ARCHIVES

Senate Confirms Elias Zerhouni For NIH Director

This article is from The Cancer Letter archive.

Vol. 28 No. 18 | May 3, 2002

Download PDF Visit The Full Archive

Related Articles

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

FDA News: Zydelig approved in three B-cell blood cancers

August 1, 2014

Also Von Eschenbach role in industry program raises new concerns of conflict of interest.

November 23, 2005

Northwestern, Rochester, Howard First In Line For Limited Construction Funds

August 20, 1976

Senate Subcommittee Adds $98 Million to NCI’s FY 1984 Budget, Assuring Substantial Increase

September 30, 1983

Harold Varmus Nominated For NIH Director; Selection Wins Support of Biomedical Community

August 13, 1993